Get started
Author

Shamia L. Faison

Observed names: Faison S, Faison, Shamia, Shamia Faison, Shamia L Faison
OpenAlex ID: A5075556362
Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults
2021 · Shamia L. Faison, Nicholas Fry, et al. · Journal of Clinical Psychopharmacology · 28
Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults
2020 · Shamia L. Faison, Nicholas Fry, et al. · Clinical Drug Investigation · 23
PDF
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma
2024 · Yazmin Odia, Carl Koschmann, et al. · Neuro-Oncology · 19
Evaluation of the Effect of SPN-812 (Viloxazine Extended-Release) on QTc Interval in Healthy Adults
2020 · Azmi Nasser, Shamia L. Faison, et al. · The Journal of Clinical Psychiatry · 19
PDF
l-tetrahydropalmatine reduces nicotine self-administration and reinstatement in rats
2016 · Shamia L. Faison, Charles W. Schindler, et al. · BMC Pharmacology and Toxicology · 16
PDF
A Phase 1 Randomized Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Escalating Oral Doses of Dordaviprone and the Effects of Food on the Bioavailability of Dordaviprone in Healthy Adult Subjects
2025 · Shamia L. Faison, Joelle Batonga, et al. · Clinical Pharmacology in Drug Development · 9
PDF
A phase 1, randomized, crossover trial to assess the effect of itraconazole on the pharmacokinetics of dordaviprone in healthy adults
2025 · Shamia L. Faison, Joelle Batonga, et al. · British Journal of Clinical Pharmacology · 5
A Phase 1 Study to Evaluate the Absorption, Metabolism, and Disposition of Dordaviprone in Healthy Adult Participants
2025 · Yohannes Teffera, Tim Tippin, et al. · Clinical Pharmacology in Drug Development · 4
PDF
Relative Bioavailability of Dordaviprone (ONC201) is Not Affected by Co‐Administration of the Proton‐Pump Inhibitor Rabeprazole
2024 · Shamia L. Faison, Joelle Batonga, et al. · The Journal of Clinical Pharmacology · 3
114 An Assessment of QTc Effects With SPN-812 (Extended-Release Viloxazine) in Healthy Adults
2020 · Azmi Nasser, Shamia L. Faison, et al. · CNS Spectrums · 3
PDF
Assessing Cytochrome P450 Drug Interaction Risk for Dordaviprone Using Physiologically Based Pharmacokinetic Modeling
2025 · Swati Jaiswal, Nikunjkumar K. Patel, et al. · CPT Pharmacometrics & Systems Pharmacology · 2
Effect of Severe Renal Impairment on Dordaviprone (ONC201) Pharmacokinetics
2025 · Shamia L. Faison, Joelle Batonga, et al. · Drugs in R&D · 2
PDF
Predicted Efficacy of Once-Daily Extended-Release Oxcarbazepine (Oxtellar XR®) Monotherapy in Adults and Children with Partial-Onset Seizures: Exposure-Response Modeling and Simulation
2020 · Shamia Faison, Roberto Gomeni, et al. · Clinical Pharmacology Advances and Applications · 1
PDF
A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Dordaviprone
2025 · Shamia L. Faison, Joelle Batonga, et al. · The Journal of Clinical Pharmacology
Utility of Cytochrome P450 4F2 Genotyping to Assess Drug Interaction Risk for Brincidovovir, a Cytochrome P450 4F2 Substrate
2024 · Tim Tippin, Shamia Faison, et al. · Clinical Pharmacology in Drug Development
Predicted Efficacy of Once-Daily Extended-Release Oxcarbazepine (Oxtellar XR®) Monotherapy in Adults and Children with Partial-Onset Seizures: Exposure-Response Modeling and Simulation
2020 · Faison S, Gomeni R, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Additional file 1: Figures S1-S6. of l-tetrahydropalmatine reduces nicotine self-administration and reinstatement in rats
2016 · Faison, Shamia, Schindler, Charles, et al. · Figshare
Works count: 19
Citation count: 134
H-index: 6
I10-index: 5
Year
Topic
Type